TCRX
TScan Therapeutics·NASDAQ
--
--(--)
--
--(--)
TCRX fundamentals
TScan Therapeutics (TCRX) released its earnings on Aug 12, 2025: revenue was 3.08M (YoY +473.88%), beat estimates; EPS was -0.28 (YoY 0.00%), beat estimates.
Revenue / YoY
3.08M
+473.88%
EPS / YoY
-0.28
0.00%
Report date
Aug 12, 2025
Earnings Call
7:00 AM on Aug 11, 2025
Meeting link.EPS
Actual | -7.69 | -0.8 | -0.6 | -0.67 | -0.63 | -0.67 | -0.78 | -0.93 | -0.51 | -0.24 | -0.21 | -0.32 | -0.28 | -0.25 | -0.3 | -0.26 | -0.28 |
Forecast | -0.645 | -0.605 | -0.7 | -0.7 | -0.744 | -0.726 | -0.724 | -0.6925 | -0.765 | -0.4526 | -0.2892 | -0.2592 | -0.2829 | -0.3154 | -0.3188 | -0.2917 | -0.3271 |
Surprise | -1092.25% | -32.23% | +14.29% | +4.29% | +15.32% | +7.71% | -7.73% | -34.30% | +33.33% | +46.97% | +27.39% | -23.46% | +1.03% | +20.74% | +5.90% | +10.87% | +14.40% |
Revenue
Actual | 2.85M | 2.41M | 2.85M | 3.02M | 4.06M | 3.36M | 3.10M | 6.80M | 3.15M | 3.89M | 7.21M | 600.00K | 536.00K | 1.05M | 665.00K | 2.17M | 3.08M |
Forecast | 3.37M | 3.48M | 3.47M | 2.76M | 3.00M | 3.93M | 4.10M | 4.87M | 4.37M | 4.45M | 3.45M | 3.98M | 1.80M | 1.17M | 1.52M | 1.08M | 1.30M |
Surprise | -15.40% | -30.67% | -17.67% | +9.64% | +35.03% | -14.43% | -24.44% | +39.72% | -28.03% | -12.66% | +108.77% | -84.91% | -70.22% | -10.54% | -56.24% | +100.09% | +135.71% |
Earnings Call
You can ask Aime
What does TScan Therapeutics do and what are its main business segments?Did TScan Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from TScan Therapeutics's earnings call?What were the key takeaways from TScan Therapeutics’s earnings call?What is TScan Therapeutics's latest dividend and current dividend yield?What is the market's earnings forecast for TScan Therapeutics next quarter?What factors drove the changes in TScan Therapeutics's revenue and profit?What guidance did TScan Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
